Trial intelligence / Profile preview

Prasugrel and edoxaban interaction study in healthy elderly Japanese men

jRCTs071190006Completed

Sponsor
Daiichi Sankyo Co., Ltd.
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of prasugrel and edoxaban (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Bleeding time. Started May 2019; status: completed.

02

Drugs

prasugreledoxaban

Beyond the preview

Go deeper on jRCTs071190006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs071190006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call